These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6277587)

  • 21. [Captopril in the hypertensive crisis].
    Maciel R; Spritzer N; Spritzer TS; Abichequer MH
    Arq Bras Cardiol; 1983 Jun; 40(6):429-31. PubMed ID: 6365045
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of angiotensin-converting enzyme in renal-transplant recipients with hypertension.
    Curtis JJ; Luke RG; Whelchel JD; Diethelm AG; Jones P; Dustan HP
    N Engl J Med; 1983 Feb; 308(7):377-81. PubMed ID: 6337328
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of captopril in the management of cardiac failure.
    Cleland JG; Dargie HJ; Robertson JI; Ball SG; Hodsman GP
    Scott Med J; 1984 Apr; 29(2):129-30. PubMed ID: 6099613
    [No Abstract]   [Full Text] [Related]  

  • 24. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Captopril in mild or moderate systemic arterial hypertension].
    Spritzer N; Wolmeister H; Spritzer TS; Maciel R
    Arq Bras Cardiol; 1984 Jun; 42(6):447-50. PubMed ID: 6393923
    [No Abstract]   [Full Text] [Related]  

  • 26. [Captopril in hypertensive crises].
    Facci Júnior C; Gonçalves LC; Dias SE; Gantois CR; Facci AM; Barbosa ET
    Arq Bras Cardiol; 1984 Jan; 42(1):73-6. PubMed ID: 6378151
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pharmacology of converting enzyme inhibitors (captopril and related products)].
    Plouin PF; Schwebig A; Alhenc-Gelas F; Corvol P; Ménard J
    Rev Prat; 1982 Jan; 32(1):65-8, 71-3. PubMed ID: 6275487
    [No Abstract]   [Full Text] [Related]  

  • 28. Cough associated with the use of captopril.
    Sesoko S; Kaneko Y
    Arch Intern Med; 1985 Aug; 145(8):1524. PubMed ID: 3896184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resolution of captopril-induced rash after substitution of enalapril.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Pharmacotherapy; 1983; 3(2 Pt 1):131-3. PubMed ID: 6304662
    [No Abstract]   [Full Text] [Related]  

  • 30. [Renin-angiotensin system blocking drugs in the diagnosis and treatment of arterial hypertension].
    Kabat M; Makowiecka-Cieśla M
    Kardiol Pol; 1984; 27(2):147-57. PubMed ID: 6328092
    [No Abstract]   [Full Text] [Related]  

  • 31. [Treatment of chronic congestive cardiac insufficiency with an orally active inhibitor of the angiotensin converting enzyme (Captopril)].
    Guerrera G; Melina D
    Minerva Cardioangiol; 1983 Mar; 31(3):93-100. PubMed ID: 6304571
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases].
    Ol'binskaia LI; Mokhova OV
    Ter Arkh; 1984; 56(11):139-42. PubMed ID: 6395426
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of essential hypertension with captopril. Possible explanation for the etiology of this disease].
    Jandrić D
    Srp Arh Celok Lek; 1983 Apr; 111(4):475-88. PubMed ID: 6364374
    [No Abstract]   [Full Text] [Related]  

  • 34. [Treatment of mild and moderate arterial hypertension with low doses of captopril].
    Alves Filho G; Santos TC; Carvalho OM; Guariento ME; Rizzalitti F; Rocha JC
    Arq Bras Cardiol; 1984 May; 42(5):377-80. PubMed ID: 6391438
    [No Abstract]   [Full Text] [Related]  

  • 35. An overview of angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Weber MA
    J Am Osteopath Assoc; 1987 Feb; 87(2 Suppl):175-80. PubMed ID: 3030978
    [No Abstract]   [Full Text] [Related]  

  • 36. [Captopril in severe arterial hypertension of childhood (authors transl)].
    Bacri JL; Dechaux M; André JL; Gagnadoux MF; Broyer M
    Arch Fr Pediatr; 1981 Dec; 38 Suppl 1():887-92. PubMed ID: 7036933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacology and therapeutic applications of the new oral angiotensin converting enzyme inhibitor, captopril.
    Ferguson RK; Vlasses PH
    Am Heart J; 1981 May; 101(5):650-6. PubMed ID: 6261570
    [No Abstract]   [Full Text] [Related]  

  • 38. [The long term effects of the oral converting enzyme inhibitor, captopril in hypertensive patients--the endocrinological study of its hypotensive mechanism (author's transl)].
    Ogihara T; Maruyama A; Naka T; Hata T; Mikami H; Nakamaru M; Gotoh S; Masuo K; Otsuka A; Tsuchiya T; Tabuchi Y; Ohde H; Kumahara Y; Iwanaga K; Yanaihara C; Ohkaru H; Yanaihara N
    Nihon Naibunpi Gakkai Zasshi; 1980 Oct; 56(10):1484-96. PubMed ID: 6256218
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The long term effect of the oral converting enzyme inhibitor captopril in hypertensive patients (author's transl)].
    Ogihara T; Maruyama A; Naka T; Mikami H; Hata T; Nakamaru M; Higaki J; Kanda T; Iwanaga K; Kumahara Y
    Nihon Naibunpi Gakkai Zasshi; 1980 Mar; 56(3):251-61. PubMed ID: 6245945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.